Keyword: sales and profits
News
15.01.2013
- Forest Laboratories posted an unexpectedly large loss in its fiscal third quarter as sales of its antidepressant Lexapro were buffeted by generic competition and sales of its...
News
09.01.2013
- Amgen, the world's largest biotechnology company, on Tuesday lowered its outlook for 2012 earnings per share by 10 cents, citing a delay in the impact of a U.S. tax credit for...
News
08.01.2013
- Monsanto, the world's largest seed company, raised its earnings outlook for fiscal 2013 on Tuesday and delivered surprisingly strong first-quarter results, citing growth in Latin...
News
08.01.2013
- Actelion, Europe's biggest biotech company, is sticking to its forecast for core earnings to return to growth from 2014 as cost cuts and a new heart and lung treatment offset...
News
08.01.2013
- Celgene on Monday forecast 2013 profit in line with Wall Street projections, introduced a long-term outlook for 2017, and said results from two late-stage trials of a drug for the...
News
07.01.2013
- Vivus said prescriptions for obesity drug Qsymia, its main product, rose nearly 68% in the month ended Dec. 21 compared with the preceding four weeks, well above industry forecasts...
News
04.01.2013
- Eli Lilly said on Friday it expects profit in 2013 to increase by more than Wall Street had been forecasting, primarily due to cost controls and improved productivity. Lilly, whose...
News
30.11.2012
- Teva Pharmaceutical Industries, the world's biggest maker of generic drugs, forecast profit and revenue for calendar 2013 that fell short of analysts' estimates. The Israel-based...
